ASTRO: Liquid Biopsy Can Stratify Risk in Oligometastatic NSCLC

WEDNESDAY, Oct. 11, 2023 -- Liquid biopsy, which identifies circulating tumor DNA (ctDNA), performed before radiotherapy (RT) can stratify risk for oligometastatic non-small cell lung cancer (NSCLC) patients, according to a study published online...